BR112014006135A2 - marcador molecular para a detecção precoce do mesotelioma pleural maligno e métodos de sua análise de expressão com o uso de amostras de derramamento pleural e de sangue - Google Patents

marcador molecular para a detecção precoce do mesotelioma pleural maligno e métodos de sua análise de expressão com o uso de amostras de derramamento pleural e de sangue

Info

Publication number
BR112014006135A2
BR112014006135A2 BR112014006135A BR112014006135A BR112014006135A2 BR 112014006135 A2 BR112014006135 A2 BR 112014006135A2 BR 112014006135 A BR112014006135 A BR 112014006135A BR 112014006135 A BR112014006135 A BR 112014006135A BR 112014006135 A2 BR112014006135 A2 BR 112014006135A2
Authority
BR
Brazil
Prior art keywords
pleural
methods
blood samples
expression analysis
molecular marker
Prior art date
Application number
BR112014006135A
Other languages
English (en)
Inventor
Masuda Hitomi
Yagi Kasumi
Ono Ken-Ichiro
Yanagisawa Kiyoshi
Yokoi Kohei
Takahashi Takashi
Takeuchi Toshiyuki
Hasegawa Yoshinori
Original Assignee
Medical & Biological Laboratories Co Ltd
Nat Univ Corp Nagoya Univ
Oncomics Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medical & Biological Laboratories Co Ltd, Nat Univ Corp Nagoya Univ, Oncomics Co Ltd filed Critical Medical & Biological Laboratories Co Ltd
Publication of BR112014006135A2 publication Critical patent/BR112014006135A2/pt

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers
    • G01N33/57423—Specifically defined cancers of lung
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/574—Immunoassay; Biospecific binding assay; Materials therefor for cancer
    • G01N33/57407—Specifically defined cancers

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Hospice & Palliative Care (AREA)
  • Analytical Chemistry (AREA)
  • Oncology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Pathology (AREA)
  • Microbiology (AREA)
  • General Physics & Mathematics (AREA)
  • Food Science & Technology (AREA)
  • Physics & Mathematics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Toxicology (AREA)
  • Peptides Or Proteins (AREA)
BR112014006135A 2011-09-15 2012-09-14 marcador molecular para a detecção precoce do mesotelioma pleural maligno e métodos de sua análise de expressão com o uso de amostras de derramamento pleural e de sangue BR112014006135A2 (pt)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2011202463 2011-09-15
PCT/JP2012/005878 WO2013038696A1 (ja) 2011-09-15 2012-09-14 胸膜中皮腫患者の早期発見のための分子マーカー及びその発現解析方法

Publications (1)

Publication Number Publication Date
BR112014006135A2 true BR112014006135A2 (pt) 2017-06-13

Family

ID=47882945

Family Applications (1)

Application Number Title Priority Date Filing Date
BR112014006135A BR112014006135A2 (pt) 2011-09-15 2012-09-14 marcador molecular para a detecção precoce do mesotelioma pleural maligno e métodos de sua análise de expressão com o uso de amostras de derramamento pleural e de sangue

Country Status (7)

Country Link
US (1) US20140363832A1 (pt)
EP (1) EP2757376A4 (pt)
JP (1) JP6276992B2 (pt)
CN (1) CN103842823B (pt)
BR (1) BR112014006135A2 (pt)
EA (1) EA201490576A1 (pt)
WO (1) WO2013038696A1 (pt)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3102601B1 (en) 2014-02-07 2020-09-02 Medlmmune, LLC Novel assay to detect human periostin
US20170307615A1 (en) * 2014-09-24 2017-10-26 Geisinger Health System Immunohistochemistry Quality Management Program Using Cultured Cell Lines for Tissue Microarray (TMA) Blocks
JP2021518387A (ja) * 2018-03-19 2021-08-02 バイオヴェンチャーズ リミテッド ライアビリティ カンパニー ペリオスチン抗体およびその使用方法
JP2022513228A (ja) * 2018-12-14 2022-02-07 ベーリンガー・インゲルハイム・イオ・カナダ・インコーポレイテッド 抗ペリオスチン抗体及びその使用
CN112941185B (zh) * 2021-03-26 2023-06-23 杭州医学院 miR-29a作为标志物在制备恶性间皮瘤检测试剂盒中的应用

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4208479A (en) * 1977-07-14 1980-06-17 Syva Company Label modified immunoassays
GB9704444D0 (en) * 1997-03-04 1997-04-23 Isis Innovation Non-invasive prenatal diagnosis
US7087727B2 (en) * 2001-08-13 2006-08-08 Dana-Farber Cancer Institute, Inc. Periostin-based diagnostic assays
KR101363695B1 (ko) 2005-12-28 2014-02-14 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 항페리오스틴에 대한 항체, 및 페리오스틴이 관여하는 질환의 예방 또는 치료를 위해 그것을 함유하는 약제학적 조성물
KR101560843B1 (ko) 2007-06-27 2015-10-15 고꾸리쯔 다이가꾸 호우징 오사까 다이가꾸 페리오스틴의 Ｅｘｏｎ-17 부위에 의해 코드되는 펩티드에 대한 항체를 함유하는 암 치료제
CN101377490B (zh) * 2007-08-30 2012-07-04 北京科美生物技术有限公司 用于检测疾病相关标志物的磁微粒分离化学发光免疫分析测定试剂盒及其制备方法
WO2010093465A1 (en) * 2009-02-11 2010-08-19 Caris Mpi, Inc. Molecular profiling of tumors
WO2011024114A1 (en) * 2009-08-25 2011-03-03 Ecole Polytechnique Federale De Lausanne (Epfl) Targeting extracellular matrix molecules for the treatment of cancer
AU2011223789A1 (en) * 2010-03-01 2012-09-20 Caris Life Sciences Switzerland Holdings Gmbh Biomarkers for theranostics

Also Published As

Publication number Publication date
EP2757376A9 (en) 2014-11-26
WO2013038696A1 (ja) 2013-03-21
JP6276992B2 (ja) 2018-02-14
EA201490576A1 (ru) 2014-09-30
CN103842823A (zh) 2014-06-04
EP2757376A4 (en) 2015-05-27
JPWO2013038696A1 (ja) 2015-03-23
EP2757376A1 (en) 2014-07-23
US20140363832A1 (en) 2014-12-11
CN103842823B (zh) 2016-05-04

Similar Documents

Publication Publication Date Title
MX2019015016A (es) Ensayos para la deteccion de una sola molecula y uso de los mismos.
BR112014002616A2 (pt) método para detectar cãncer pancreático e reagente ou kit para detectar câncer pancreático
BR112014007440A2 (pt) lâmina de reagentes unificada e métodos para detectar a presença ou ausência de ponta de pipeta dentro da bainha de pipeta e para determinar o comprimento de ponta de pipeta dentro de bainha de pipeta da mesma
EP3259067A4 (en) Devices for biological sample collection and analysis and methods of use thereof
ES2982079T3 (es) Métodos y aparatos para la detección no destructiva de partículas no disueltas en un fluido
BR112013016708A2 (pt) otimização de análise multigene de amostras de tumor
BR112014007789A2 (pt) sistemas e métodos para análise biológica
DK3511423T4 (da) Fremgangsmåder og produkt til optimering af lokaliseret eller rumlig detektion af genekspression i en vævsprøve
BR112015001592A2 (pt) análise de imagem e medidas de amostras biológicas
BR112014010696A2 (pt) método para identificar uma molécula de analito em uma amostra biológica, sensor para capturar um analito de interesse de uma amostra biológica, e, detector
BR112015019614A2 (pt) análise de imagens e medições de amostras biológicas
BR112014002219A2 (pt) conjugados anticorpo p97 e métodos de sua utilização
BRPI1006172A2 (pt) sistema e metodo para amostrar e analisar fluidos de formacao de fundo de poco
BR112013022995A8 (pt) método e sistema para análise e detecção de célula
BR112013022735A2 (pt) aparelho para processamento de uma amostra, aparelho para processamento de uma pluralidade de amostras, método para detectar a presença ou ausência de um analito em uma amostra e método para detectar a presença ou ausência de um analito em uma pluralidade de amostras
BR112016028944A2 (pt) kit ou dispositivo para a detecção de câncer do trato biliar e método de detecção
BRPI0908669A2 (pt) dispositivo para coletas de amostras e métodos de uso
CO6680668A2 (es) Ensayos biomarcadores para detectar o medir inhibición de actividad quinasa tor
SMT201400145B (it) Metodo per la rivelazione di anticorpi aBeta-specifici in un campione biologico
EP2684036A4 (en) SYSTEMS AND METHODS FOR HIGH SPEED DETECTION OF SUBSTANCE TO BE ANALYZED IN SAMPLE
BR112014006135A2 (pt) marcador molecular para a detecção precoce do mesotelioma pleural maligno e métodos de sua análise de expressão com o uso de amostras de derramamento pleural e de sangue
BR112014015557A2 (pt) sistema e método para detectar propriedades de material de fluido de fundo de poço
DK2751725T3 (da) Anvendelse af kernemagnetisk resonans og nær-infrarød til analyse af biologiske prøver
HK1186767A1 (zh) 用於分析受試者血樣中疾病標記物的存在的方法
BR112014012045A2 (pt) métodos para detectar analito em amostra e para detectar um patógeno em um ferimento em um indivíduo